RB
Renovaro Biosciences Inc
🇺🇸XNAS.RENBUnited StatesHealthcare
$2.19USDup +0.02 (+0.92%)ClosedEnd of day9:46 PM
Price$2.19+0.02 (+0.92%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US29350E1047
- CUSIP
- 236078101
Company
- Employees
- 25
- Headquarters
- Los Angeles, United States
- Website
- https://renovarogroup.com
Market
- Shares outstanding
- 23.2M
- Market cap
- $50.76M
Highlights
- Market cap
- $50.76M
- EPS LTM
- -$10.03
- P/E LTM
- -0.22calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $181.45K+100%up year on year
- Net income
- -$178.01M-98.41%down year on year
- Gross margin
- 46.84%
- Free cash flow
- $11.8T+104,986,572.47%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.